Pharmacological Control of Calcium and Potassium Homeostasis Biological, Therapeutical, and Clinical Aspects.
General Material Designation
[Book]
First Statement of Responsibility
Godfraind, T.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Springer Verlag
Date of Publication, Distribution, etc.
2013
CONTENTS NOTE
Text of Note
Preface. I: Molecular biology and pharmacology of cell calcium and potassium. II: Calcium and potassium regulation in cardiovascular pathophysiology. III: Calcium antagonists in cardiovascular therapy and organ protection. IV: Calcium and potassium manipulation in the prevention and reversal of structural changes in hypertension. V: Beyond blood pressure reduction: tissue protection by calcium antagonism can be enhanced by ACE inhibitors. VI: Multicenter Israpidine diuretic atherosclerosis study (MIDAS): results and lessons learned. VII: Calcium and potassium homeostasis in cerebral ischemia and neurodegenerative disorders. VIII: Molecular and clinical aspects of current and novel uses of potassium channel openers. Index.